Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

9926

1

EGAIN Corp eGain Corporation Reports Decline in Revenue and Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9927

1

GlobalTech Corp GlobalTech Corporation Reports 77% Revenue Growth, Net Loss Improvement in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9928

1

MOTORCAR PARTS OF AMERICA INC Motorcar Parts of America Reports 5.9% Net Sales Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9929

1

PROTHENA CORP PUBLIC LTD CO Prothena Corporation Reports Significant Revenue Decline, Net Loss in Q3 2024, Despite 46% Revenue Growth for Nine Months

Via official filing (AI summary) | 6 months ago | 0 comments

9930

1

FibroBiologics Inc. FibroBiologics Reports Mixed Financial Results, Advances Product Candidates Amid Regulatory Challenges

Via official filing (AI summary) | 6 months ago | 0 comments

9931

1

KALA BIO, Inc. KALA Bio Reports Q3 2024 Financial Results, Ongoing Challenges and Strategic Developments

Via official filing (AI summary) | 6 months ago | 0 comments

9932

1

ALLIANCE ENTERTAINMENT HOLDING CORP Alliance Entertainment Reports Strong Financial Results, Notable Revenue Growth in Vinyl and Physical Movie Sales

Via official filing (AI summary) | 6 months ago | 0 comments

9933

1

Voyager Therapeutics, Inc. Voyager Therapeutics Reports Improved Financials, Increased Collaboration Revenue in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9934

1

CYANOTECH CORP Cyanotech Reports 8.3% Decline in Quarterly Sales, Net Loss Amid Macroeconomic Challenges

Via official filing (AI summary) | 6 months ago | 0 comments

9935

1

GeoVax Labs, Inc. GeoVax Labs Reports Increased Cash and Revenue, But Remains Concerned About Funding

Via official filing (AI summary) | 6 months ago | 0 comments

9936

1

TELOS CORP Telos Corporation Reports Significant Financial Challenges in Latest Quarter, Sees Revenue Decline and Net Loss

Via official filing (AI summary) | 6 months ago | 0 comments

9937

1

Paragon 28, Inc. Paragon 28 Reports 18% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9938

1

Tectonic Therapeutic, Inc. Tectonic Therapeutic Reports Significant Financial Changes Following Merger, Anticipates Ongoing Expenses for Research and Development

Via official filing (AI summary) | 6 months ago | 0 comments

9939

1

BANK OF THE JAMES FINANCIAL GROUP INC Bank of the James Financial Group Reports Mixed Q3 Results, Asset Growth, and Expansion Plans

Via official filing (AI summary) | 6 months ago | 0 comments

9940

1

Ark 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF Reports $3.2 Billion in Assets, 36% Growth in Bitcoin Prices

Via official filing (AI summary) | 6 months ago | 0 comments

9941

1

21Shares Core Ethereum ETF 21Shares Core Ethereum ETF Reports $12.6M in Assets, 24.24% Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9942

1

Sky Harbour Group Corp Sky Harbour Group Reports 64% Revenue Growth, Wider Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9943

1

Zentalis Pharmaceuticals, Inc. Zentalis Pharmaceuticals Reports Improved Financial Results, Reduced Losses, and Increased Cash Reserves

Via official filing (AI summary) | 6 months ago | 0 comments

9944

1

Runway Growth Finance Corp. Runway Growth Finance Corp. Reports Decline in Investment Income and Net Asset Value

Via official filing (AI summary) | 6 months ago | 0 comments

9945

1

Climb Bio, Inc. Climb Bio Reports Significant Financial Developments, Net Loss Increases 124.2% in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9946

1

Fractyl Health, Inc. Fractyl Health Reports Financial Improvements, Revenue Decline in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9947

1

Kalaris Therapeutics, Inc. AlloVir Reports Reduced Operating Expenses, Net Losses, and Cash Increase in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9948

1

Savara Inc Savara Inc. Reports Financial Results, Advances Molgramostim Development for Rare Respiratory Disease

Via official filing (AI summary) | 6 months ago | 0 comments

9949

1

Pluri Inc. Pluri Inc. Reports Revenue Growth, Net Loss in Q3 2024, Amid Cost Reduction Efforts and Strategic Developments

Via official filing (AI summary) | 6 months ago | 0 comments

9950

1

CBL & ASSOCIATES PROPERTIES INC CBL & Associates Properties Reports Mixed Q3 Results, Net Income Turnaround

Via official filing (AI summary) | 6 months ago | 0 comments